Browsing through the 4th module of the Covid Inquiry report, we came across this statement in the section called Covid-19 vaccines (page 16 of the document): risks, benefits and how to prepare for the next pandemic. The Lead Author was Professor Daniel Prieto-Alhambra.
Due to a lack of resources (a problem not experienced by Baroness Hallett and her apparatus), we took one look at a randomised controlled trial cited to support the now defunct Oxford AstraZeneca vaccine (now known as VaxZevria).
Share
We chose this because we have already painstakingly dissected the regulatory evidence for PfizerBioNTech’s Comirnaty in 46 posts and follow-ups. For once, we thought we would look at a publication (in this case, the illustrious Lancet) rather than bore our readers with endless regulatory bumf. “Truth at last, peer-reviewed gold dust!” We hear you scream.
